Adalimumab vs Rituximab

## Adalimumab vs Rituximab: Overview

This comparison examines the pharmacological differences between **Adalimumab** and **Rituximab**.

## Mechanism of Action

**Adalimumab**: Fully human anti-TNF-alpha monoclonal antibody.

**Rituximab**: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.

## Pharmacokinetics

**Half-life**: Adalimumab — 14 days; Rituximab — 22 days.

## Chemical Properties

**Type**: Adalimumab — Antibody; Rituximab — Antibody.